col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Wiley: The Journal of Clinical Pharmacology
  original article Date Title Authors   All Authors
1 [GO] 2021―Dec―18 Association between baseline use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers and death among patients tested for COVID-19 Sarah A. Thomas, Michael Puskarich, Michael S. Pulia, Andrew C. Meltzer, Carlos A. Camargo, D. Mark Courtney, et al. (+3)
2 [GO] 2021―Nov―21 Off-label use of hydroxychloroquine in COVID-19: analysis of reports of suspected adverse reactions from the Italian National Network of Pharmacovigilance Elettra Fallani, Fabio Cevenini, Pietro Enea Lazzerini, Annalisa Verdini, Simona Saponara
3 [GO] 2021―Nov―18 Clearance of lormetazepam, midazolam, and their conjugated metabolites by continuous venovenous hemofiltration during prolonged sedation in critically ill patients with COVID-19-associated acute respiratory distress syndrome Kimberly N. Shudofsky, Paddy K. C. Janssen, N. Foudraine, Jos L. M. L. Noble
4 [GO] 2021―Aug―05 The Risk of SARS-COV-2 Infection and Covid-19 Severity Associated with The Exposure to Non-Steroidal Anti-Inflammatory Drugs: Systematic Review and Meta-Analysis Luísa Prada, Catarina D. Santos, Rita A. Baião, João Costa, Joaquim J. Ferreira, Daniel Caldeira
5 [GO] 2021―Jul―01 Corticosteroids in COVID-19: We should be mindful of its acute toxicities Mitesh Karn, Sapana Yonghang, Sadikshya Ghimire
6 [GO] 2021―Jun―22 Therapeutic Application of Corticosteroids in COVID-19: A Focus on Optimum Dose and Duration of Therapy Sajad Khiali, Taher Entezari-Maleki
7 [GO] 2021―Apr―28 Pharmacological Predictors of Morbidity and Mortality in COVID-19 Christopher Oddy, James McCaul, Polly Keeling, Jonathan Allington, Dhanuja Senn, Neesha Soni, et al. (+4)
8 [GO] 2021―Apr―19 Baricitinib: From Rheumatoid Arthritis to COVID-19 5 Sara Assadiasl, Yousef Fatahi, Banafsheh Mosharmovahed, Bahareh Mohebbi, Mohammad Hossein Nicknam
9 [GO] 2021―Apr―07 Clinical Equipoise in COVID-19 Vaccine Candidates Trials Rafael Dal-Ré
10 [GO] 2021―Feb―26 The Interplay between the Immune System, the Renin Angiotensin Aldosterone System (RAAS) and RAAS Inhibitors May Modulate the Outcome of COVID-19: A Systematic Review Hiba Naveed, Abdallah Elshafeey, Dana Al-Ali, Emmad Janjua, Areej Nauman, Hussam Kawas, et al. (+4)
11 [GO] 2021―Jan―29 Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based Review Elnaz Khani, Sajad Khiali, Taher Entezari-Maleki
12 [GO] 2021―Jan―21 AAMC Discusses Monoclonal Antibody Therapeutics for SARS-CoV-2 Infection Vera S. Donnenberg
13 [GO] 2020―Dec―18 Amantadine for COVID-19 Paweł Grieb, Maciej Świątkiewicz, Katarzyna Prus, Konrad Rejdak
14 [GO] 2020―Dec―04 Science and Evidence-based Review and Approval of COVID-19 Vaccines: A Statement of Support for the U.S. FDA Sudhakar M. Pai, Ahmed A. Othman, Lorraine Rusch, Joanna C. Masters, Douglas Greene, Mark Rogge, et al. (+8)
15 [GO] 2020―Nov―21 Antiretrovirals for prophylaxis against COVID-19; a comprehensive literature review Golbarg Alavian, Kasra Kolahdouzan, Masoud Mortezazadeh, Zahra Sadat Torabi
16 [GO] 2020―Nov―12 Treatment with Tocilizumab for Patients with Covid-19 Infections: A Case-series Study Yoonsun Mo, Obed Adarkwah, John Zeibeq, Evgeny Pinelis, Jose Orsini, James Gasperino
17 [GO] 2020―Sep―04 Empiric therapeutic anticoagulation and mortality in critically ill patients with respiratory failure from SARS-CoV-2: A retrospective cohort study John Ferguson, Stacy Volk, Thomas Vondracek, John Flanigan, Andrew Chernaik
18 [GO] 2020―Aug―11 Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology Considerations Ping Ji, Jianmeng Chen, Amit Golding, Nikolay P. Nikolov, Bhawana Saluja, Yunzhao R. Ren, Chandrahas Sahajwalla
19 [GO] 2020―Jul―01 Overmedication in COVID-19 context: a report from Peru Raisa N. Martinez-Rivera, Alvaro Taype-Rondan
20 [GO] 2020―Jun―24 Clinical pharmacology considerations for developing small molecule treatments for COVID-19 Priya Brunsdon, Bhawana Saluja, Chandrahas Sahajwalla
21 [GO] 2020―Jun―19 A Comprehensive Review on Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome Sajad Khiali, Elnaz Khani, Taher Entezari-Maleki
22 [GO] 2020―Jun―14 Critical Need for Implementation of Clinical Pharmacology Principles in Developing Drugs for the Treatment or Prevention of COVID-19 Gina Pastino
23 [GO] 2020―Jun―12 Why your Patients’ Believing Hydroxychloroquine and Chloroquine are 90% Effective for COVID-19 is 100% Dangerous C. Michael White, Adrian V. Hernandez
24 [GO] 2020―Jun―08 Colchicine and COVID-19 Pablo Corral, Gonzalo Corral, Rafael Diaz
25 [GO] 2020―May―29 A Comprehensive Updated Review on SARS-CoV-2 and COVID-19 Yunzhao R. Ren, Amit Golding, Alfred Sorbello, Ping Ji, Jianmeng Chen, Saluja Bhawana, et al. (+6)
26 [GO] 2020―May―29 Evaluation of potential therapeutic options for COVID-19 Daren Austin, Malek Okour
27 [GO] 2020―May―23 Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19? Somayyeh Nasiripour, Farhad Zamani, Maryam Farasatinasab
28 [GO] 2020―May―22 Severe Acute Lung Injury Related to COVID-19 Infection: A Review and the Possible Role for Escin Luca Gallelli, Leiming Zhang, Tian Wang, Fenghua Fu
29 [GO] 2020―May―21 Intuitive Global Insight Into COVID-19 Clinical Research Activities-The “COVID-19 Map of Hope” Markus Ries, Konstantin Mechler, Donna L. Smith, Benjamin Herfort, Johannes Visintini, Amon Veiga Santana, et al. (+2)
30 [GO] 2020―May―21 TMPRSS2: Potential Biomarker for COVID-19 Outcomes Jonathan D. Strope, Cindy H. Chau, PharmD, William D. Figg
31 [GO] 2020―May―20 Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes? Bruno Mégarbane, Jean-Michel Scherrmann


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.010 sec